Report cover image

MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review

Publisher GlobalData
Published Nov 13, 2024
Length 54 Pages
SKU # GBDT19339212

Description

MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review


Table of Contents

54 Pages
Section 1 - About the Company
MediGene AG - Key Facts
MediGene AG - Key Employees
MediGene AG - Key Employee Biographies
MediGene AG - Major Products and Services
MediGene AG - History
MediGene AG - Company Statement
MediGene AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MediGene AG - Business Description
MediGene AG - Corporate Strategy
MediGene AG - SWOT Analysis
SWOT Analysis - Overview
MediGene AG - Strengths
MediGene AG - Weaknesses
MediGene AG - Opportunities
MediGene AG - Threats
MediGene AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
MediGene AG, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
MediGene AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 11, 2024: Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
Oct 17, 2024: Medigene Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024
Oct 16, 2024: Medigene to Present at Upcoming Scientific Conferences
Oct 02, 2024: Medigene will Present at ASGCT 2024 and Host R&D Event
Aug 29, 2024: Medigene AG Secures Two Additional Patents for Technologies in Its End-To-End Platform
Aug 29, 2024: Medigene Secures Two Additional Patents For Technologies In Its End-to-end Platform
Aug 14, 2024: Medigene Reports Half-Year 2024 Financial Results and Provides Corporate Update
Aug 08, 2024: Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
Jul 23, 2024: Medigene to Present at ESMO Congress 2024
Jun 24, 2024: Medigene Reports Results of Annual General Meeting
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
MediGene AG, Key Facts
MediGene AG, Key Employees
MediGene AG, Key Employee Biographies
MediGene AG, Major Products and Services
MediGene AG, History
MediGene AG, Subsidiaries
MediGene AG, Key Competitors
MediGene AG, Ratios based on current share price
MediGene AG, Annual Ratios
MediGene AG, Annual Ratios (Cont...1)
MediGene AG, Annual Ratios (Cont...2)
MediGene AG, Interim Ratios
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
MediGene AG, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
MediGene AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
MediGene AG, Performance Chart (2019 - 2023)
MediGene AG, Ratio Charts
MediGene AG, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
MediGene AG, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.